Enzon Pharmaceuticals News (NASDAQ:ENZN)
| Latest Enzon Pharmaceuticals News Headlines | | Date | Time | Source | | | 09/26/2007 | 7:00AM | PRNUS | Jeffrey H. Buchalter Joins MacroGenics Board of Directors as Chairman
ROCKVILLE, Md., Sept. 26 /PRNewswire/ -- MacroGenics, Inc. announced today that Mr. Jeffrey H. Buchalter has been elected as Chairman of the company's Board of Directors. With more than 20 years of experience in product development and commercialization in the pharmaceutical and biotechnology industry, Mr. Buchalter... More...>> |
| 09/12/2005 | 10:01AM | PRNUS | StayinFront to Provide Enzon Pharmaceuticals with Integrated CRM and Data Quality Solutions
- StayinFront's Turnkey Services to Drive Sales Force Effectiveness
FAIRFIELD, N.J., Sept. 12 /PRNewswire/ -- StayinFront, Inc., a global provider of enterprise wide customer relationship management (CRM) applications, decision support tools, data services and eBusiness systems, today announced that Enzon Pharmaceuticals... More...>> |
| 12/03/2004 | 9:46AM | PRNUS | MORNING UPDATE: Man Securities Issues Alerts for TWX, GPS, NGEN, TOY, and ENZN
MORNING UPDATE: Man Securities Issues Alerts for TWX, GPS, NGEN,
TOY, and ENZN
CHICAGO, Dec. 3 /PRNewswire/ -- Man Securities issues the following Morning
Update at 8:30 AM EST with new PriceWatch Alerts for key stocks.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/MANSECLOGO )
Before the open... PriceWatch... More...>> |
| 05/12/2004 | 4:33PM | PRNUS | Efficacy Data on PEG-INTRON(R) and REBETOL(R) in Wide Range of Hepatitis Patient Populations to Be Presented at Digestive Diseas
Efficacy Data on PEG-INTRON(R) and REBETOL(R) in Wide Range of
Hepatitis Patient Populations to Be Presented at Digestive Disease WEEK (DDW)
Annual Meeting in New Orleans
Researchers Present 48 Abstracts on Schering-Plough Interferon Products
KENILWORTH, N.J., May 12 /PRNewswire-FirstCall/ -- Important new data on the
efficacy... More...>> |
| 04/21/2004 | 10:00PM | PRNUS | Schering-Plough Submits New Drug Application (J-NDA) in Japan for PEG-INTRON(R) and REBETOL(R) Combination Therapy for Hepatitis
Schering-Plough Submits New Drug Application (J-NDA) in Japan for
PEG-INTRON(R) and REBETOL(R) Combination Therapy for Hepatitis C
KENILWORTH, N.J., April 21 /PRNewswire-FirstCall/ -- Schering-Plough
Corporation today announced that Schering-Plough K.K., the company's
subsidiary in Japan, has submitted a New Drug Application... More...>> |
| 03/24/2004 | 2:51PM | PRNUS | ProSanos SSEER Technology Powers New Registry
ProSanos SSEER Technology Powers New Registry
LA JOLLA, Calif., March 24 /PRNewswire/ -- A new approach to the creation of
registries and clinical databases is being unveiled to researchers today.
SSEER(TM) (Simultaneous Secure Electronic Entry and Reporting), from ProSanos(R)
Corporation of La Jolla CA, was used to... More...>> |
| 02/23/2004 | 9:36AM | PRNUS | MORNING UPDATE: Man Securities Issues Alerts for HPQ, L, CE, HLIT, And ENZN
MORNING UPDATE: Man Securities Issues Alerts for HPQ, L, CE, HLIT, And ENZN
CHICAGO, Feb. 23 /PRNewswire/ -- Man Securities issues the following Morning
Update at 8:30 AM EST with new PriceWatch Alerts for key stocks.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/MANSECLOGO )
Before the open... PriceWatch Alerts... More...>> |
| 11/24/2003 | 8:54AM | PRNUS | Study Shows Assessing Early Virologic Response (EVR) To PEG-INTRON(R) Weight-Based Therapy For Hepatitis C Can Reduce Treatment
Study Shows Assessing Early Virologic Response (EVR) To PEG-INTRON(R)
Weight-Based Therapy For Hepatitis C Can Reduce Treatment Duration and Costs
Analysis of Economic and Clinical Effects of Evaluating EVR Published in The
American Journal of Gastroenterology
KENILWORTH, N.J., Nov. 24 /PRNewswire-FirstCall/ -- Assessment... More...>> |
|
|
|